It’s hard to believe that it’s already been a year since the “c” word came into my life. Sadly, the word in question wasn’t “cashback.” Hearing the phrase “poorly differentiated squamous cell ...

Julie Brahmer, MD, discusses the unique features of the phase 3 CheckMate 9LA trial in patients with metastatic non–small cell lung cancer.

The differential diagnosis includes squamous cell carcinoma ... 1987), and another died of a poorly differentiated carcinoma of the lung; again, unrelated to the PKMB (Bargman, 1985).

This group of patients represents a significant and growing segment of the head and neck cancer population with high unmet need. This large patient population is currently poorly served by agents ...

The following is a summary of “Radiologic Imaging Aids Management of High-risk Cutaneous Squamous Cell Carcinoma ... and were moderately/poorly differentiated, with a larger diameter, depth beyond fat ...

Patients with primary Merkel cell carcinoma are at an increased risk of developing a secondary skin cancer vs other malignancies.

Oral squamous cell carcinoma (OSCC) is a leading cause of cancer-related deaths, and early detection is key to improving ...

In the Phase III HARMONi-6 trial, ivonescimab plus chemotherapy significantly outperformed tislelizumab plus chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer.

A biopsy reveals squamous cell carcinoma (SCC) in situ. What should be the next steps in the patient's evaluation and management? After the initial consultation, the patient's biopsy specimen was ...